ExpreS2ion’s U.S. partner Integrated BioTherapeutics launches first ExpreS2-based research product
ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its U.S.-based partner and licensee Integrated BioTherapeutics (“IBT”) has initiated sales and marketin...
Continue Reading →
